[Biological characteristics of residual leukemic cells and their drug-resistant regrowth].
OBJECTIVE: To elucidate the mechanisms of residual leukemia and its drug-resistant regrowth. METHODS: Bone marrow cells from transplantable mouse leukemia models L615 and L7811 were cultivated in long-term culture system respectively. Daunorubicin (DNR) was added to the systems to mimick in vivo chemotherapy. RESULTS: Residual leukemic cells on stromal layers escaped DNR killing. They derived from the adherent leukemic cell population, which was heterogeneous with many undifferentiated and dormant cells. They were drug-resistant and expressed bcl-2 gene. CONCLUSION: Bone marrow stromal layer was the vital microenvironment for the residual leukemic cells to survive and regrow, and might increase the drug-resistance by up-regulating bcl-2 gene expression.